UPDATE: Danaher Q1 Revenues Rise 5 Percent; CEO Culp Retiring Next Year | GenomeWeb

The story has been updated to include comments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Wednesday that total revenues for the first quarter increased 5 percent year over year as revenues from its Life Sciences and Diagnostics segment rose nearly 6 percent.

The company also announced that its President and CEO Lawrence Culp will retire on March 1, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.